Gapping up
In reaction to earnings/guidance:
- CGNX +5.4%, APOG +1.7%
Other news:
- ROIV +12.3% (files $1 bln mixed securities shelf offering)
- PPTA +6.1% (receives DOD funding to study antimony from Stibnite Gold Project)
- STN +4.7% (awarded $16 mln feasibility study for Resolution Copper)
- SOUN +4.3% (stock offering by selling shareholders)
- OUST +2.6% (announced a comprehensive cost reduction initiative across its business streamlining its cost structure and extending its expected cash runway)
- DBTX +2.3% (submission of an Investigational New Drug application for a Phase 1/2 clinical trial in pediatric patients of DB-OTO)
- BA +2.2% (met with regulators in China about returning 737 Max to flight according to Reuters)
- WVE +2.1% (update to the ongoing Phase 1b/2a SELECT-HD clinical trial of WVE-003 the company's clinical candidate for Huntington's disease)
- PTON +1.6% (releases Peloton Row)
- AMX +1% (informs about the listing of Sitios Latinoamérica S.A.B. de C.V. incorporated as result of AMX's spin-off (Sitios Latam); also upgraded to Buy from Neutral at UBS)
- CLPT +0.9% (obtains 510k clearance)